Cover Image
Market Research Report

Global Hepatocyte Growth Factor Market Research Report 2018

Published by QYResearch Product code 603242
Published Content info 131 Pages
Delivery time: 3-5 business days
Price
Back to Top
Global Hepatocyte Growth Factor Market Research Report 2018
Published: February 5, 2018 Content info: 131 Pages
Description

This report studies the Hepatocyte Growth Factor market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Hepatocyte Growth Factor market by product type and applications/end industries.

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

For developing product, there are 3 products in Phase 3, 7 products in Phase 2, 3 products in Phase 1 and 2 products in Preclinical. The total investment for hepatocyte growth factor developing is around 42 M USD in 2017.

The major players in global Hepatocyte Growth Factor market include:

  • ViroMed
  • AnGes MG
  • M3 Biotechnology
  • AVEO Pharmaceuticals
  • Molecular Partners
  • Yooyoung Pharm
  • F-star
  • Galaxy Biotech
  • Kringle Pharma

Geographically, this report is segmented into several key regions, with market size and R&D investment, market share and growth rate of hepatocyte growth factor in these regions, from 2013 to 2030 (forecast), covering:

  • North America
  • Europe
  • Asia Pacific
  • RoW

On the basis on the end users/applications, this report covers:

  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Hematological Disorders
  • Others
Table of Contents

Table of Contents

1. Hepatocyte Growth Factor Market Overview

  • 1.1. Hepatocyte Growth Factor Product Overview
  • 1.2. Hepatocyte Growth Factor Segment by Pipeline
  • 1.3. Hepatocyte Growth Factor Segment by Application
    • 1.3.1. Global Hepatocyte Growth Factor R&D Investment and Growth Rate Comparison by Application (2013-2023)
    • 1.3.2. Global Hepatocyte Growth Factor R&D Investment Market Share by Application in 2017
  • 1.4. Global Hepatocyte Growth Factor Market by Regions (2017-2030)
    • 1.4.1. Global Hepatocyte Growth Factor Market Size and Growth Rate Comparison by Regions (2017-2030)
    • 1.4.2. North America Hepatocyte Growth Factor Status and Prospect (2017-2030)
    • 1.4.3. Europe Hepatocyte Growth Factor Status and Prospect (2017-2030)
    • 1.4.4. Asia Pacific Hepatocyte Growth Factor Status and Prospect (2017-2030)
  • 1.5. Global Hepatocyte Growth Factor Market Size (2017-2030)
  • 1.6. Information about HGF Plasmid DNA

2. Global Hepatocyte Growth Factor Market Competition by Manufacturers

  • 2.1. Global Hepatocyte Growth Factor Pipeline of Key Players/Manufacturers
  • 2.2. Global Hepatocyte Growth Factor R&D Investment and Share by Manufacturers (2016-2017)
  • 2.3. Manufacturers Hepatocyte Growth Factor Headquarters, Established, Product Types
  • 2.4. Hepatocyte Growth Factor Market Competitive Situation and Trends
    • 2.4.1. Hepatocyte Growth Factor R&D Investment Concentration Rate
    • 2.4.2. Hepatocyte Growth Factor R&D Investment Share of Top 3 and Top 5 Manufacturers
    • 2.4.3. Mergers & Acquisitions, Expansion

3. Global Hepatocyte Growth Factor R&D Investment by Regions (2013-2018)

  • 3.1. Global Hepatocyte Growth Factor Developer Distribution by Regions
  • 3.2. Global Hepatocyte Growth Factor R&D Investment and Market Share by Regions (2013-2018)
  • 3.3. Global Hepatocyte Growth Factor R&D Investment and Growth Rate (2013-2018)
  • 3.4. North America Hepatocyte Growth Factor R&D Investment and Growth Rate (2013-2018)
  • 3.5. Europe Hepatocyte Growth Factor R&D Investment and Growth Rate (2013-2018)
  • 3.6. Asia Pacific Hepatocyte Growth Factor R&D Investment and Growth Rate (2013-2018)

4. Global Hepatocyte Growth Factor Market Size by Regions (2017-2030)

  • 4.1. Global Hepatocyte Growth Factor Consumption by Regions (2017-2030)
  • 4.2. North America Hepatocyte Growth Factor Market Size (2017-2030)
  • 4.3. Europe Hepatocyte Growth Factor Market Size (2017-2030)
  • 4.4. Asia Pacific Hepatocyte Growth Factor Market Size (2017-2030)

5. Global Hepatocyte Growth Factor R&D Investment by Application

  • 5.1. Global Hepatocyte Growth Factor Manufacturers Product, Clinical Stage and Treatment Area
    • 5.1.1. Hepatocyte Growth Factor Manufacturers Product, Clinical Stage and Treatment Area
    • 5.1.2. VM202
    • 5.1.3. AMG0001
    • 5.1.4. NDX-1017
    • 5.1.5. Ficlatuzumab (AV-299)
    • 5.1.6. MP0250
    • 5.1.7. YYB 101(NOV1105)
    • 5.1.8. FS101mAb2
    • 5.1.9. HuL2G7
    • 5.1.10. HGF Recombinant protein
  • 5.2. Global Hepatocyte Growth Factor Investment by Application (2013-2018)
  • 5.3. Global Hepatocyte Growth Factor Market Size by Application (2017-2030)

6. Analysis of Hepatocyte Growth Factor Industry Key Manufacturers

  • 6.1. ViroMed
    • 6.1.1. Company Profile
    • 6.1.2. Product Information
    • 6.1.3. Product, Stage and R&D Investment
  • 6.2. AnGes MG
    • 6.2.1. Company Profile
    • 6.2.2. Product Information
    • 6.2.3. Product, Stage and R&D Investment
  • 6.3. M3. Biotechnology
    • 6.3.1. Company Profile
    • 6.3.2. Product Information
    • 6.3.3. Product, Stage and R&D Investment
  • 6.4. AVEO Pharmaceuticals
    • 6.4.1. Company Profile
    • 6.4.2. Product Information
    • 6.4.3. Product, Stage and R&D Investment
  • 6.5. Molecular Partners
    • 6.5.1. Company Profile
    • 6.5.2. Product Information
    • 6.5.3. Product, Stage and R&D Investment
  • 6.6. Yooyoung Pharm
    • 6.6.1. Company Profile
    • 6.6.2. Product Information
    • 6.6.3. Product, Stage and R&D Investment
  • 6.7. F-star
    • 6.7.1. Company Profile
    • 6.7.2. Product Information
    • 6.7.3. Product, Stage and R&D Investment
  • 6.8. Galaxy Biotech
    • 6.8.1. Company Profile
    • 6.8.2. Product Information
    • 6.8.3. Product, Stage and R&D Investment
  • 6.9. Kringle Pharma
    • 6.9.1. Company Profile
    • 6.9.2. Product Information
    • 6.9.3. Product, Stage and R&D Investment

7. Hepatocyte Growth Factor Manufacturing Cost Analysis

  • 7.1. Hepatocyte Growth Factor R&D Cost Analysis

7.1.1Clinical Phase Costs 64

    • 7.1.2. Capitalized Costs
  • 7.2. Proportion of Manufacturing Cost Structure
    • 7.2.1. Raw Materials
    • 7.2.2. Labor Cost Analysis
    • 7.2.3. Other Costs Analysis
    • 7.2.4. Manufacturing Expenses
  • 7.3. Manufacturing Process Analysis of Hepatocyte Growth Factor

8. Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 8.1. Hepatocyte Growth Factor Industrial Chain Analysis
  • 8.2. Upstream Raw Materials Sourcing
  • 8.3. Downstream Buyers

9. Marketing Strategy Analysis, Distributors/Traders

  • 9.1. Marketing Channel
    • 9.1.1. Direct Marketing
    • 9.1.2. Indirect Marketing
    • 9.1.3. Marketing Channel Development Trend
  • 9.2. Market Positioning
    • 9.2.1. Pricing Strategy
    • 9.2.2. Brand Strategy
  • 9.3. Distributors/Traders List

10. Market Effect Factors Analysis

  • 10.1. Technology Progress
  • 10.2. Consumer Needs/Customer Preference Change
  • 10.3. Economic/Political Environmental Change

11. Global Hepatocyte Growth Factor Market Forecast (2018-2030)

  • 11.1. Global Hepatocyte Growth Factor R&D Investment and Market Size Forecast
    • 11.1.1. Global Hepatocyte Growth Factor R&D Investment and Growth Rate Forecast (2018-2023)
    • 11.1.2. Global Hepatocyte Growth Factor Market Size and Growth Rate Forecast (2018-2030)
  • 11.2. Global Hepatocyte Growth Factor R&D Investment Forecast by Regions (2018-2023)
    • 11.2.1. North America Hepatocyte Growth Factor R&D Investment Forecast (2018-2023)
    • 11.2.2. Europe Hepatocyte Growth Factor R&D Investment Forecast (2017-2022)
    • 11.2.3. Asia Pacific Hepatocyte Growth Factor R&D Investment Forecast (2017-2022)
  • 11.3. Global Hepatocyte Growth Factor Market Size Forecast by Regions (2018-2030)
    • 11.3.1. North America Hepatocyte Growth Factor Market Size Forecast (2018-2025)
    • 11.3.2. Europe Hepatocyte Growth Factor Market Size Forecast (2018-2025)
    • 11.3.3. Asia Pacific Hepatocyte Growth Factor Market Size Forecast (2018-2025)
  • 11.4. Global Hepatocyte Growth Factor R&D Investment Forecast by Application (2018-2023)
  • 11.5. Global Hepatocyte Growth Factor Market Size Forecast by Application (2018-2025)

12. Research Findings and Conclusion

13. Methodology and Data Source

  • 13.1. Methodology/Research Approach
    • 13.1.1. Research Programs/Design
    • 13.1.2. Market Size Estimation
    • 13.1.3. Market Breakdown and Data Triangulation
  • 13.2. Data Source
    • 13.2.1. Secondary Sources
    • 13.2.2. Primary Sources
  • 13.3. Disclaimer
  • 13.4. Author List

List of Tables and Figures

  • Figure Product Picture of Hepatocyte Growth Factor
  • Table Global Hepatocyte Growth Factor Manufacturers Product, Clinical Stage and Treatment Area
  • Table Global Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate Comparison by Application (2013-2023)
  • Figure Global Hepatocyte Growth Factor R&D Investment Market Share by Application in 2017
  • Figure Global Hepatocyte Growth Factor Market Size (M USD) Comparison and Growth Rate by Regions (2017-2030)
  • Table Hepatocyte Growth Factor Market Size (M USD) Comparison by Regions (2017-2030)
  • Figure North America Hepatocyte Growth Factor Market Size (M USD) and Growth Rate (2017-2030)
  • Figure Europe Hepatocyte Growth Factor Revenue (M USD) and Growth Rate (2017-2030)
  • Figure Asia Pacific Hepatocyte Growth Factor Revenue (M USD) and Growth Rate (2017-2030)
  • Figure Global Hepatocyte Growth Factor Market Size (M USD) Status and Outlook (2017-2030)
  • Table HGF plasmid DNA Developer, Product, Clinical Stage and Treatment Area
  • Table Global Hepatocyte Growth Factor R&D Investment (K USD) of Key Manufacturers (2016-2017)
  • Table Global Hepatocyte Growth Factor R&D Investment Share by Manufacturers (2016-2017)
  • Figure 2016 Hepatocyte Growth Factor R&D Investment Share by Manufacturers
  • Figure 2017 Hepatocyte Growth Factor R&D Investment Share by Manufacturers
  • Table Manufacturers Hepatocyte Growth Factor Product Category
  • Table Manufacturers Hepatocyte Growth Factor Headquarters and Established
  • Table Manufacturers Hepatocyte Growth Factor Product Category
  • Figure 2017 Hepatocyte Growth Factor R&D Investment Share by Manufacturers
  • Figure Hepatocyte Growth Factor R&D Investment Share of Top 3 Manufacturers
  • Figure Hepatocyte Growth Factor R&D Investment Share of Top 5 Manufacturers
  • Table Global Hepatocyte Growth Factor Developer Distribution by Regions in 2017
  • Table Global Hepatocyte Growth Factor R&D Investment (K USD) by Regions (2013-2018)
  • Table Global Hepatocyte Growth Factor R&D Investment Market Share by Regions (2013-2018)
  • Figure Global Hepatocyte Growth Factor R&D Investment Market Share by Regions (2013-2018)
  • Figure 2017 Global Hepatocyte Growth Factor R&D Investment Market Share by Regions
  • Figure Global Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate (2013-2018)
  • Figure North America Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate (2013-2018)
  • Figure Europe Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate (2013-2018)
  • Figure Asia Pacific Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate (2013-2018)
  • Table Global Hepatocyte Growth Factor Market Size (M USD) by Regions (2017-2023)
  • Table Global Hepatocyte Growth Factor Market Size (M USD) by Regions (2024-2030)
  • Table Global Hepatocyte Growth Factor Consumption Market Share by Regions (2017-2023)
  • Table Global Hepatocyte Growth Factor Consumption Market Share by Regions (2024-2030)
  • Figure Global Hepatocyte Growth Factor Consumption Market Share by Regions (2017-2030)
  • Figure 2030 Global Hepatocyte Growth Factor Consumption Market Share by Regions
  • Figure North America Hepatocyte Growth Factor Market Size (M USD) and Growth Rate (2017-2030)
  • Figure Europe Hepatocyte Growth Factor Market Size (M USD) and Growth Rate (2017-2030)
  • Figure Asia Pacific Hepatocyte Growth Factor Market Size (M USD) and Growth Rate (2017-2030)
  • Table Global Hepatocyte Growth Factor Manufacturers Product, Clinical Stage and Treatment Area
  • Table Global Hepatocyte Growth Factor R&D Investment (K USD) by Application (2013-2018)
  • Table Global Hepatocyte Growth Factor R&D Investment Share by Application (2013-2018)
  • Figure R&D Investment Market Share of Hepatocyte Growth Factor by Application (2013-2018)
  • Figure 2013 R&D Investment Market Share of Hepatocyte Growth Factor by Application
  • Figure 2017 R&D Investment Market Share of Hepatocyte Growth Factor by Application
  • Table Global Hepatocyte Growth Factor Market Size (M USD) by Application (2017-2023)
  • Table Global Hepatocyte Growth Factor Market Size (M USD) by Application (2024-2030)
  • Table Global Hepatocyte Growth Factor Consumption Market Share by Application (2017-2023)
  • Table Global Hepatocyte Growth Factor Consumption Market Share by Application (2024-2030)
  • Figure Global Hepatocyte Growth Factor Consumption Market Share by Application (2017-2030)
  • Figure 2030 Global Hepatocyte Growth Factor Consumption Market Share by Application
  • Table ViroMed Company Profile
  • Table Hepatocyte Growth Factor Introduction of ViroMed
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of ViroMed 2015-2016
  • Table AnGes MG Company Profile
  • Table Hepatocyte Growth Factor Introduction of AnGes MG
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of AnGes MG 2015-2016
  • Table M3 Biotechnology Company Profile
  • Table Hepatocyte Growth Factor Introduction of M3 Biotechnology
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of M3 Biotechnology 2015-2016
  • Table AVEO Pharmaceuticals Company Profile
  • Table Hepatocyte Growth Factor Introduction of AVEO Pharmaceuticals
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of AVEO Pharmaceuticals 2015-2016
  • Table Molecular Partners Company Profile
  • Table Hepatocyte Growth Factor Introduction of Molecular Partners
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of Molecular Partners 2015-2016
  • Table Yooyoung Pharm Company Profile
  • Table Hepatocyte Growth Factor Introduction of Yooyoung Pharm
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of Yooyoung Pharm 2015-2016
  • Table F-star Company Profile
  • Table Hepatocyte Growth Factor Introduction of F-star
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of F-star 2015-2016
  • Table Galaxy Biotech Company Profile
  • Table Hepatocyte Growth Factor Introduction of Galaxy Biotech
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of Galaxy Biotech 2015-2016
  • Table Kringle Pharma Company Profile
  • Table Hepatocyte Growth Factor Introduction of Kringle Pharma
  • Table Hepatocyte Growth Factor Product, Stage and R&D Investment (K USD) of Kringle Pharma 2015-2016
  • Figure typical phases from research to the market for a drug candidate
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
  • Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Figure Manufacturing Cost Structure of Hepatocyte Growth Factor
  • Figure Assessment of API Manufacturing Cost By Region
  • Figure USA Labor Cost Analysis 2012-2016
  • Figure Cost of Employing a Factory Worker
  • Figure 2016 Estimated Labour Costs for the Whole Economy in Europe
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Labor Costs 2013-2016
  • Table Average Price of Electricity to Ultimate Customers 2007-2016
  • Figure Electricity Prices for Household Consumers in 2016
  • Figure Summary of the Driving Assumptions
  • Figure Industrial Electric Rates 2016 (PER KWH)
  • Figure Manufacturing Process Analysis of Hepatocyte Growth Factor
  • Figure Hepatocyte Growth Factor Industrial Chain Analysis
  • Table Major Buyers of Hepatocyte Growth Factor
  • Figure Marketing Channel for Biopharmaceuticals
  • Table Distributors/Traders List
  • Figure Global GDP Growth Rate for 2016
  • Figure US GDP 2006-2016 (Billion USD)
  • Figure US CPI Change 2016-2017
  • Figure EU GDP 2006-2016 (Billion USD)
  • Figure EU CPI Change 2012-2016
  • Figure Germany GDP 2006-2016 (Billion USD)
  • Figure Germany CPI Change 2016-2017
  • Figure UK GDP 2006-2016 (Billion USD)
  • Figure UK CPI Change 2016-2017
  • Figure Italy GDP 2006-2016 (Billion USD)
  • Figure Italy CPI Change 2016-2017
  • Figure Japan GDP 2006-2016 (Billion USD)
  • Figure Japan CPI Change 2012-2016
  • Figure China GDP 2006-2016 (Billion USD)
  • Figure China CPI Change 2016-2017
  • Figure Global Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate Forecast (2018-2023)
  • Figure Global Hepatocyte Growth Factor Market Size (M USD) and Growth Rate Forecast (2018-2030)
  • Table Global Hepatocyte Growth Factor R&D Investment (K USD) Forecast by Regions (2018-2023)
  • Table Global Hepatocyte Growth Factor R&D Investment Market Share Forecast by Regions (2018-2023)
  • Figure Global Hepatocyte Growth Factor R&D Investment Market Share Forecast by Regions (2018-2023)
  • Figure North America Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate Forecast (2018-2023)
  • Figure Europe Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate Forecast (2017-2022)
  • Figure Asia Pacific Hepatocyte Growth Factor R&D Investment (K USD) and Growth Rate Forecast (2017-2022)
  • Table Global Hepatocyte Growth Factor Market Size (M USD) Forecast by Regions (2018-2024)
  • Table Global Hepatocyte Growth Factor Market Size (M USD) Forecast by Regions (2024-2030)
  • Figure Global Hepatocyte Growth Factor Market Size Share Forecast by Regions (2018-2030)
  • Figure North America Hepatocyte Growth Factor Market Size (M USD) and Growth Rate Forecast (2018-2025)
  • Figure Europe Hepatocyte Growth Factor Market Size (M USD) and Growth Rate Forecast (2018-2025)
  • Figure Asia Pacific Hepatocyte Growth Factor Market Size (M USD) and Growth Rate Forecast (2018-2025)
  • Table Global Hepatocyte Growth Factor R&D Investment (K USD) Forecast by Application (2018-2023)
  • Table Global Hepatocyte Growth Factor R&D Investment Share Forecast by Type (2018-2023)
  • Figure Global Hepatocyte Growth Factor R&D Investment Share Forecast by Type (2018-2023)
  • Table Global Hepatocyte Growth Factor Market Size (M USD) Forecast by Application (2018-2024)
  • Table Global Hepatocyte Growth Factor Market Size (M USD) Forecast by Application (2024-2030)
  • Figure Global Hepatocyte Growth Factor Consumption Forecast by Application (2018-2030)
Back to Top